Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**ProC3G** is a proprietary dietary ingredient developed by ChromaDex, consisting of a natural black rice extract standardized to contain 40% **cyanidin-3-glucoside (C3G)**, a potent anthocyanin. C3G acts as a powerful antioxidant, scavenging free radicals and supporting cellular health through modulation of oxidative stress pathways. Marketed for use in dietary supplements, it targets wellness applications such as metabolic support and anti-aging, backed by ChromaDex's intellectual property and research collaborations.[2][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProC3G.